Clinical Trials Logo

Filter by:
NCT ID: NCT05735145 Recruiting - Clinical trials for Uterine Cervical Neoplasms

Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer

Start date: July 1, 2022
Phase: Phase 3
Study type: Interventional

This study carried out a prospective, randomized, controlled clinical study under the background of intensity-modulated radiation therapy and three-dimensional afterloading therapy. By comparing simultaneous intensity-modulated radiotherapy and chemotherapy combined with adjuvant chemotherapy and simultaneous intensity-modulated radiotherapy and chemotherapy alone, based on the 2018 FIGO staging The clinical efficacy of locally advanced cervical cancer further clarifies the role of adjuvant chemotherapy in locally advanced cervical cancer.

NCT ID: NCT05735132 Active, not recruiting - Clinical trials for Efficiency and Safey of Radial Artery Cannulation

Novel Local Infiltration Anesthesia for Radial Artery Cannulation.

Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This clinical trial aims to compare the pain scores and cannulation success rates of conventional, bar-shaped, and V-shaped local infiltration anesthesia in participants' radial artery cannulation. The main questions it aims to answer are: - Are bar-shaped and V-shaped more successful than the conventional block in radial artery cannulation? - Are bar-shaped and V-shaped less painful than the conventional block in radial artery cannulation? Participants will describe their pain score during their radial artery cannulation. Researchers will compare the pain scores and cannulation success rates in bar-shaped, V-shaped, and conventional line blocking to see if bar-shaped and V-shaped blocking is better choices than conventional line blocking.

NCT ID: NCT05735054 Active, not recruiting - Thyroid Diseases Clinical Trials

A Novel Technique for Endoscopic Transaxillary Thyroidectomy Comparison

Start date: January 1, 2021
Phase:
Study type: Observational

The clinical data from all except the first 20 cases who underwent our novel transaxillary thyroidectomy were collected retrospectively, while the data from patients who underwent conventional open thyroid lobectomy by same surgeon during the same period were used as a control.

NCT ID: NCT05735041 Active, not recruiting - Clinical trials for Mild Cognitive Impairment

Computerized Cognitive Training in Patients With Coronary Heart Disease and Mild Cognitive Impairment

COG-T CHD
Start date: January 18, 2023
Phase: N/A
Study type: Interventional

In this study, a multicentre, double-blind, randomized controlled study based on cognitive training was conducted in patients with coronary heart disease and cognitive impairment but without dementia, to evaluate the effectiveness of computer-based digital therapy in improving the cognitive function of such patients.

NCT ID: NCT05735028 Recruiting - Lung Cancer Clinical Trials

The Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Centipeda Minima (CM) in Lung Cancer

Start date: February 7, 2024
Phase: Phase 1
Study type: Interventional

Lung cancer has a high global cancer morbidity and mortality. At present, PD-1/PD-L1 inhibitors have been approved by FDA to treat different types of lung cancer, but the efficacy is not good. There is an urgent need to develop drugs that can significantly enhance the efficacy of PD-1/PD-L1 inhibitors to enable tumor patients to obtain lasting anti-tumor response. Centipeda minima (CM), as a commonly used traditional Chinese medicine, is relatively safe. Previous studies found that it can inhibit the growth of lung cancer cells. At the level of animal research, the combined use of CM and PD-1/PD-L1 inhibitors produced a stronger anti-lung cancer effect, and did not produce obvious side effects on mice. Based on previous studies, the main purpose of this study was to evaluate the efficacy and safety of PD-1/PD-L inhibitors combined with herbivorous herbivores (CM) in the treatment of lung cancer.

NCT ID: NCT05734911 Completed - Ovarian Neoplasms Clinical Trials

Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study

Start date: January 1, 2019
Phase:
Study type: Observational [Patient Registry]

In order to explore the real situation of niraparib in clinical application more comprehensively and deeply, we conducted the first multicenter, real-world study in China. This large observational study used real-world data to assess the effectiveness and safety of niraparib as maintenance therapy in patients with advanced ovarian cancer (AOC) in China and investigated clinical factors associated with prolonged benefits of niraparib so as to achieve the maximum clinical benefit of patients.

NCT ID: NCT05734898 Recruiting - AML Clinical Trials

NKG2D CAR-NK & r/rAML

Start date: March 2023
Phase: N/A
Study type: Interventional

This trial will explore the maximum tolerated dose(MTD)of NKG2D CAR-NK cells in the treatment of relapsed or/and refractory AML in a dose-escalation manner, and observe the clinical safety and efficacy.

NCT ID: NCT05734872 Recruiting - Clinical trials for Non-suicidal Self-injury

Research on the Intervention of VR-based Emotion Regulation Technology on Adolescent Non-suicide Self-injury Behavior

VR
Start date: October 26, 2022
Phase: N/A
Study type: Interventional

Non suicidal self injury (NSSI) has become a serious social and public health problem allover the world, and the incidence rate is increasing year by year. Although the aim of NSSI is not to suicide, but its negative impact is extremely serious, which will seriously threaten the physical and mental health of adolescents. Virtual Reality (VR), a computer simulation technology, can enable people to enter and experience the artificial virtual world in an immersive way, has been used for the auxiliary treatment of anxiety disorder, post-traumatic stress disorder and other diseases. This study explored the impact of VR on the depression and mental health of NSSI adolescents, so as to reduce the incidence of non-suicide self-injury behavior in NSSI adolescent patients and improve the quality of life of such patients.

NCT ID: NCT05734807 Active, not recruiting - Clinical trials for Chronic HBV Infection

A Study to Evaluate the Antiviral Activity and Safety of HH-003 in Chronic Hepatitis B Subjects With Low-level Viremia

Start date: July 20, 2022
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, controlled Phase IIa study of HH-003 to evaluate the antiviral activity and safety in nucleos(t)ide analogues-treated chronic hepatitis B subjects with low-level viremia. HH-003 is a human monoclonal antibody targeting the pre-S1 domain of the HBV large envelope protein. It blocks engagement of preS1 with sodium taurocholate co-transporting polypeptide (NTCP), the cellular receptor for HBV.

NCT ID: NCT05734794 Recruiting - Clinical trials for Nephrotic Syndrome in Children

Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial

STORM
Start date: February 9, 2023
Phase: Phase 3
Study type: Interventional

The main objective is to evaluate the effectiveness of Rituximab monotherapy versus steroid therapy on children with new-onset nephrotic syndrome within the 52-week follow-up.